Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

What new data tell us about TAVR in women with a history of early menopause

Researchers examined data from more than 700 TAVR patients, publishing their findings in the American Journal of Cardiology.

Thumbnail

Cardiologists warn Biden administration that new policies could put PAD patients at risk

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

Thumbnail

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

An attendee tries out a hands-on TEE simulator in a packed GE Healthcare booth at ACC.23. Photo by Dave Fornell

ACC.23 emerges as a return to normalcy for the cardiology community

Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic. 

B. Hadley Wilson, ACC President ACC.23

New American College of Cardiology President B. Hadley Wilson shares his goals for the future

The veteran interventional cardiologist told Cardiovascular Business he sees potential in the ACC's ability to grow both nationally and internationally in the next year. 

Thumbnail

Keto-like diets linked to increased risk of high cholesterol, heart disease

New research, presented during ACC.23/WCC in New Orleans, has raised fresh concerns about the potential cardiovascular-related drawbacks of high-fat, low-carbohydrate diets. 

Atul Verma, MD, head of cardiology at McGill University Health Centre

Day 3 at ACC.23 features late-breaking studies on pulsed-field ablation, other new technologies

The third and final day of ACC.23 featured a key update on Medtronic's pulsed-field ablation technology and many other late-breaking clinical studies. 

Thumbnail

Infertility linked to a higher risk of coronary heart disease

The associations were strongest for women who experienced infertility at the age of 25 or younger. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.